This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Discussing Lilly's insulin efsitora alfa (efsitora), a once weekly injection compared to a once daily basal insulin injection which is currently in development for the treatment of diabetes.

Ticker(s): LLY

Who's the expert?

  • Completed her medical degree at University of Belgrade, as well as a postdoctoral fellowship at the George Washington Universitt and a master in clinical pharmacology at University of Belgrade.
  • Completed internship and residency in internal medicine at Interfaith Medical Center and completed fellowship in endocrinology at David Geffen School of Medicine at UCLA. 

Interview Goal
This conversation will focus on the treatment landscape and potential use of Lilly's insulin efsitora alfa in the treatment of diabetes. 

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.